The Provision of Blood Stem Cell Products

The public procurement process, led by University Hospitals Plymouth, involves the provision of blood stem cell products, including haematopoietic stem cells, bone marrow stem cells, and lymphocytes transplants. This service falls under the industry category of services provided by transplant organ banks (CPV code: 85146200) and is located at University Hospitals Plymouth, Derriford Road, Plymouth. The procurement stage is at the award stage, with the contract being officially signed on 13th May 2025.

The procurement method employed was a direct award under the Provider Selection Regime (PSR), specifically Regulation 7, and is set outside the traditional scope of competitive tendering. The services are contracted for a duration of three years to Anthony Nolan, the supplier, due to their ability to meet high-quality care standards and ensure patient safety. This tender creates valuable opportunities for businesses experienced in healthcare services, particularly those specialising in transplant organ services.

With the focus on continuous high-quality service delivery, businesses that can demonstrate excellence in healthcare provision and the ability to maintain stringent service outcomes would be well-suited to engage with similar future procurement processes. Entities with a track record of successful healthcare operations, particularly in niche medical services, have the potential to capitalise on such exclusive contracts, enhancing their portfolio and expanding their reach within the vital health sector market.